Patents by Inventor Ian Tarpey

Ian Tarpey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Poultry virus vaccines that are liquid stable
    Patent number: 9827305
    Abstract: The present invention is drawn to liquid stable poultry vaccines that comprise avian virus. The invention is also drawn to the manufacture of such vaccines methods of vaccinating animal subjects with these vaccines.
    Type: Grant
    Filed: February 16, 2015
    Date of Patent: November 28, 2017
    Assignee: Intervet Inc.
    Inventors: Zhisong Qiao, Stephanie Cook, Kevin O'Connell, Ian Tarpey
  • POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE
    Publication number: 20160346381
    Abstract: The present invention is drawn to liquid stable poultry vaccines that comprise avian virus. The invention is also drawn to the manufacture of such vaccines methods of vaccinating animal subjects with these vaccines.
    Type: Application
    Filed: February 16, 2015
    Publication date: December 1, 2016
    Applicant: INTERVET INC.
    Inventors: Zhisong Qiao, Stephanie Cook, Kevin O'Connell, Ian Tarpey
  • ANTIBODIES AGAINST CANINE PD-1
    Publication number: 20160333096
    Abstract: The present invention discloses antibodies to canine PD-1 that have specific sequences and a high binding affinity for canine PD-1. The invention also discloses the use of the antibodies of the present invention in the treatment of cancer in dogs.
    Type: Application
    Filed: December 19, 2014
    Publication date: November 17, 2016
    Applicant: Intervet Inc.
    Inventors: Mohamad Morsey, Yuanzheng Zhang, Denise Bartels-Morozov, Jason Erskine, Ian Tarpey
  • CANINIZED MURINE ANTIBODIES TO HUMAN PD-1
    Publication number: 20160319018
    Abstract: The present invention provides caninized murine anti-human PD-1 antibodies that have specific sequences and a high binding affinity for canine PD-1. The invention also relates to use of these antibodies in the treatment of dogs.
    Type: Application
    Filed: December 19, 2014
    Publication date: November 3, 2016
    Applicant: Intervet Inc.
    Inventors: Mohamad Morsey, Yuanzheng Zhang, Denise Bartels-Morozov, Jason Erskine, Ian Tarpey, Leonard G. Presta
  • CANINIZED ANTIBODIES
    Publication number: 20160311902
    Abstract: The present invention discloses caninized antibodies with specific properties. The present invention also discloses caninized murine antibodies againstcanine PD-1 that have a high binding affinity for canine PD-1. The invention further discloses the use of the caninized antibodies of the present invention in the treatment of cancer in dogs.
    Type: Application
    Filed: December 19, 2014
    Publication date: October 27, 2016
    Applicant: Intervet Inc.
    Inventors: Mohamad Morsey, Yuanzheng Zhang, Ian Tarpey
  • Infectious bronchitis virus with an altered spike gene
    Patent number: 7445785
    Abstract: The present invention provides a vaccine for use in the protection of poultry against infectious bronchitis comprising an attenuated infectious bronchitis virus (IBV) and a pharmaceutical acceptable carrier or diluent, characterized in that the attenuated IBV comprises a heterologous spike gene. Such a vaccine is based on IBV strain Beaudette that is able to express a spike gone derived from a different IBV strain. The vaccines provided by the present invention also allow the administration via the in ovo route.
    Type: Grant
    Filed: March 3, 2004
    Date of Patent: November 4, 2008
    Assignees: Intervet International B.V., Institute for Animal Health
    Inventors: David Cavanagh, Paul Britton, Ian Tarpey
  • Infectious bronchitis virus with an altered spike gene
    Publication number: 20070154489
    Abstract: The present invention provides a vaccine for use in the protection of poultry against infectious bronchitis comprising an attenuated infectious bronchitis virus (IBV) and a pharmaceutical acceptable carrier or diluent, characterized in that the attenuated IBV comprises a heterologous spike gene. Such a vaccine is based on IBV strain Beaudette that is able to express a spike gone derived from a different IBV strain. The vaccines provided by the present invention also allow the administration via the in ovo route.
    Type: Application
    Filed: March 3, 2004
    Publication date: July 5, 2007
    Inventors: David Cavanagh, Paul Britton, Ian Tarpey
  • Canine parvovirus DNA vaccination
    Patent number: 6187759
    Abstract: This invention relates to the use of a DNA vaccine for the manufacture of a medicament for use in eliciting an immune response against parvovirus in a maternally derived antibody positive animals. The DNA vaccine comprises a plasmid vector and at least one isolated nucleotide sequence encoding a parvovirus immunogenic polypeptide, and transcriptional regulatory sequences operably linked to the isolated nucleotide sequence.
    Type: Grant
    Filed: February 12, 1998
    Date of Patent: February 13, 2001
    Assignee: Akzo Nobel N.V.
    Inventors: Ian Tarpey, Neil Greenwood